Plain-English translation of NCT06458764 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study is looking at sexual health concerns that may develop in women who had early-stage breast cancer surgery and are taking hormone therapy (endocrine therapy). Researchers want to understand how common these concerns are, how much they affect quality of life, and what symptoms women experience most often. The goal is to gather information that will help doctors support survivors better and design future treatments to address these concerns.
Women treated for breast cancer with hormone therapy often experience changes in sexual function, but this issue isn't well studied or discussed. By understanding how widespread these concerns are and what causes them, doctors can better support survivors and eventually test new ways to help.
You would complete questionnaires about your sexual health, quality of life, and any symptoms you've experienced since starting hormone therapy. There are no medications to take or procedures to undergo โ this is purely a survey-based study where you share your experiences. The study collects information once (it's not a long-term follow-up) to help researchers understand survivors' needs and design future support programs.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
Italy
Enrollment target
~150 participants
Started
May 2023
Primary completion
December 2025
Age range
18 Years โ 55 Years
Sex
Female only
Last updated on clinicaltrials.gov in June 2025.